Immunological and molecular biological analyzes of cell surface antigens associated with T cell activation and function
与 T 细胞活化和功能相关的细胞表面抗原的免疫学和分子生物学分析
基本信息
- 批准号:06670242
- 负责人:
- 金额:$ 1.34万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for General Scientific Research (C)
- 财政年份:1994
- 资助国家:日本
- 起止时间:1994 至 1995
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Autoimmune diseases result from self-tissue destruction caused by auto-reactive immune responses which are not elicited in normal human and mine. We have analyzed immunological abnormalities in autoimmune-prone MRL/lpr mice, particularly graft-versus-host disease (GVHD) -like disorders obeserved in [MRL/lpr -> MRL/+] bone marrow chimeras. In these studies, two interesting monoclonal autoantibodies (25T3 and F6C7) reactive with white blood cells have been established. 25T3 monoclonal antibody (mAb) (IgM,k) is specific for T cells, and reacts to 70-80% peripheral CD8^+ T cells and 30% peripheral CD4^+ T cells. 25T3^+CD4^+T cells secret more IL-2 than 25T3^-CD4^+T cels, and 25T3^-CD4^+T cells secret more IL-4 than 25T3^+CD4^+T cells after in vitro stimulation with anti-CD3 mAb. Therefore, 25T3 mAb may divide CD4^+T cells into Th1 and Th2 subpopulaitons. The 25T3-reactive antigen is approximately 70 kDa. F6C7 mAb (IgG2b, k) strongly reacts to blastic T cells activated by autologous MLR and … More some blastic T cells of MRL/lpr mice. The F6C7-reactive antigen is a heterodimer of approximately 78 and 70 kDa. Although these antigens are not cloned, these mAbs are usuful for analyzing T cell abnormalities in immunological disorders. We have further established nephritogenic mAbs from FGS or (NZW X BXSB) F1 mice which spontaneously develop glomerulonephritis. When the mAbs are transplanted into SCID mice, the mice show proteinuria and glomerulonephritis. FG1H5 mAb (IgM,k) reacts both ssDNA and glomerulus (mainly mesangium), and deposits in the glomeruli. The FG1H5 reactive antigen is approximately 28 kDa. W/B4A9 mAb (IgM,k) deposits along systemic capillary walls in cluding kidney, heart and etc. The mAb reacts to approximately 25 kDa plasma protein. W/B2A4 mAb (IgG3, k) is a cryoglobulin, deposits mainly in glomerular capillary walls and induced high level of proteinuria. These nephritogenic mAbs may elucidate the nephritogenic antigens and contribute to understanding the mechanisms underlying the development of glomerulonephritis. Less
自身免疫性疾病是由自身免疫反应引起的自身组织破坏引起的,而正常人和我的体内不会引起这种免疫反应。我们分析了自身免疫易感MRL/lpr小鼠的免疫异常,特别是在[MRL/lpr -> MRL/+]骨髓嵌合体中观察到的移植物抗宿主病(GVHD)样疾病。在这些研究中,两个有趣的单克隆自身抗体(25 T3和F6 C7)反应的白色血细胞已经建立。25 T3单克隆抗体(mAb)(IgM,k)对T细胞具有特异性,可与70-80%的外周血CD 8 ^+ T细胞和30%的外周血CD 4 ^+ T细胞反应。在体外用抗CD 3 mAb刺激后,25 T3 ^+ CD 4 ^+T细胞比25 T3 ^-CD 4 ^+ T细胞分泌更多的IL-2,25 T3 ^-CD 4 ^+T细胞比25 T3 ^+ CD 4 ^+T细胞分泌更多的IL-4。因此,25 T3 mAb可将CD 4 ^+T细胞分为Th 1和Th 2亚群。25 T3反应性抗原约为70 kDa。F6 C7 mAb(IgG 2b,k)与自体MLR激活的原始T细胞强烈反应, ...更多信息 MRL/lpr小鼠的一些原始T细胞。F6 C7反应性抗原是约78和70 kDa的异源二聚体。虽然这些抗原没有被克隆,但这些mAb用于分析免疫性疾病中的T细胞异常。我们进一步从自发发生肾小球肾炎的FGS或(NZW X BXSB)F1小鼠中建立了致肾炎单克隆抗体。当将mAb移植到SCID小鼠中时,小鼠显示蛋白尿和肾小球肾炎。FG 1H 5 mAb(IgM,k)与ssDNA和肾小球(主要是系膜)反应,并沉积在肾小球中。FG 1H 5反应性抗原约为28 kDa。W/B4 A9 mAb(IgM,k)可沿着全身毛细血管壁沉积,包括肾脏、心脏等。mAb可与约25 kDa的血浆蛋白反应。W/B2 A4 mAb(IgG 3,k)是一种cryocellulin,主要沉积在肾小球毛细血管壁,并引起高水平的蛋白尿。这些致肾炎单克隆抗体可以阐明致肾炎抗原,并有助于了解肾小球肾炎发生的机制。少
项目成果
期刊论文数量(56)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Hosaka N,Nose M,Nagata N,et al.: "Aging of the thymus is a critical factor in successful bone marrow transplantation : Bone marrow transplantation plus fetal thymus grafts as a strategy for treatment of autoimmune diseases in old MRL/+ mice." Proc. Natl.
Hosaka N、Nose M、Nagata N 等人:“胸腺老化是骨髓移植成功的关键因素:骨髓移植加胎儿胸腺移植作为治疗老年 MRL/小鼠自身免疫性疾病的策略。”
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Hosaka N,Nose M,Nagata N,Miyashima S,Kyogoku M,Ikehara S: "Aging of the thymus is a critical factor in successful bone marrow transplantation : bone marrow Transplantation plus fetal thymus graft as a strategy for treatment of autoimmune disease in old MR
Hosaka N,Nose M,Nagata N,Miyashima S,Kyogoku M,Ikehara S:“胸腺的老化是成功骨髓移植的关键因素:骨髓移植加胎儿胸腺移植作为治疗老年自身免疫性疾病的策略
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Hosaka N,Nagata N,et al.: "Attenuation of lpr-GVHD in MRL/lpr spleen cell-injected SCID mice by in vivo treatment with anti-Vβ8.1,2 monoclonal antibody." Clin. Exp. Immunol.96. 500-507 (1994)
Hosaka N、Nagata N 等人:“通过抗 Vβ8.1,2 单克隆抗体体内治疗来减弱 MRL/lpr 脾细胞注射的 SCID 小鼠中的 lpr-GVHD”。 500-507 (1994)
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Ishida T,Inaba M,Hisha H,Sugiura K,Adachi Y,Nagata N,Ogawa R,Good R A,Ikehara S: "Requirement of donor-derived stromal cells in the bone marrow for successful allogeneic bone marrow transplantation : complete prevention of recurrence of autoimmune disease
Ishida T,Inaba M,Hisha H,Sugiura K,Adachi Y,Nagata N,Okawa R,Good RA,Ikehara S:“成功同种异体骨髓移植需要骨髓中的供体来源的基质细胞:完全预防复发
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Nishimura M,Toki J,Sugiura K,Hashimoto F,Tomita T,Fujishima H,Hiramatsu Y,Nishioka N,Nagata N,Takahashi Y,Ikehara S: "Focal segmental glomerular sclerosis, a type of intractable chronic glomerulonephritis, is a stem cell disorder." J.Exp.Med.179 (3). 1053
Nishimura M,Toki J,Sugiura K,Hashimoto F,Tomita T,Fujishima H,Hiramatsu Y,Nishioka N,Nagata N,Takahashi Y,Ikehara S:“局灶节段性肾小球硬化症,一种顽固性慢性肾小球肾炎,是一种干细胞
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
NAGATA Norikazu其他文献
NAGATA Norikazu的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('NAGATA Norikazu', 18)}}的其他基金
Auto-MHC class II-reactive T cell line obtained from MRL mice
从 MRL 小鼠获得的自身 MHC II 类反应性 T 细胞系
- 批准号:
02670162 - 财政年份:1990
- 资助金额:
$ 1.34万 - 项目类别:
Grant-in-Aid for General Scientific Research (C)
相似海外基金
PHASE 1 TRIAL FOR A THERAPEUTIC MONOCLONAL ANTIBODY FOR CHIKUNGUNYA VIRUS
基孔肯雅病毒治疗性单克隆抗体的第一阶段试验
- 批准号:
10892414 - 财政年份:2023
- 资助金额:
$ 1.34万 - 项目类别:
Base Title: PREVENT Preclinical Pharmacology and ToxicologyTask Order Title: Nicotine Reduction Therapy Using the Human Monoclonal Antibody ATI-1013
基本标题:预防临床前药理学和毒理学任务订单标题:使用人单克隆抗体 ATI-1013 进行尼古丁减少治疗
- 批准号:
10932479 - 财政年份:2023
- 资助金额:
$ 1.34万 - 项目类别:
Monoclonal Antibody to Combat Pseudomonas Aeruginosa
对抗铜绿假单胞菌的单克隆抗体
- 批准号:
10674274 - 财政年份:2023
- 资助金额:
$ 1.34万 - 项目类别:
Monoclonal Antibody Cocktail for Treatment of Marburg Virus Disease
用于治疗马尔堡病毒病的单克隆抗体混合物
- 批准号:
10761372 - 财政年份:2023
- 资助金额:
$ 1.34万 - 项目类别:
Targeting a ectonucleotidase in the heart with a monoclonal antibody to prevent post-infarct heart failure
用单克隆抗体靶向心脏中的核酸外切酶以预防梗死后心力衰竭
- 批准号:
10711469 - 财政年份:2023
- 资助金额:
$ 1.34万 - 项目类别:
Epitope-directed monoclonal antibody production for mosquito immune cells (for malaria)
针对蚊子免疫细胞(针对疟疾)的表位定向单克隆抗体生产
- 批准号:
10933280 - 财政年份:2023
- 资助金额:
$ 1.34万 - 项目类别:
On-cell screening of mouse hybridomas for improved monoclonal antibody discovery
小鼠杂交瘤的细胞筛选以改进单克隆抗体的发现
- 批准号:
10696698 - 财政年份:2023
- 资助金额:
$ 1.34万 - 项目类别:
Assessment of self-association of monoclonal antibody molecules by analysis of the protein layer detected at the proximity of a solid surface
通过分析在固体表面附近检测到的蛋白质层来评估单克隆抗体分子的自缔合
- 批准号:
10726173 - 财政年份:2023
- 资助金额:
$ 1.34万 - 项目类别:
STTR Phase I: Developing antifouling viral clearance membranes to enable efficient monoclonal antibody (mAb) processing
STTR 第一阶段:开发防污病毒清除膜以实现高效的单克隆抗体 (mAb) 处理
- 批准号:
2212947 - 财政年份:2022
- 资助金额:
$ 1.34万 - 项目类别:
Standard Grant
Development of transportable scFV monoclonal antibody into nucleus
可转运的scFV单克隆抗体进入细胞核的开发
- 批准号:
22K19387 - 财政年份:2022
- 资助金额:
$ 1.34万 - 项目类别:
Grant-in-Aid for Challenging Research (Exploratory)














{{item.name}}会员




